Hexone glucokinase inhibitor and use thereof

PH12021551635B1Active Publication Date: 2026-11-06SHANDONG XUANZHU PHARMA TECH CO LTD +1
0 Cites 0 Cited by

Patent Information

Application Number
PH12021551635
Authority / Receiving Office
PH · PH
Patent Type
Patents
Current Assignee / Owner
Filing Date
2021-07-06
Publication Date
2026-11-06
Estimated Expiration
2041-07-06
Patent Text Reader

Abstract

The present invention relates to the technical field of pharmaceuticals, and in particular to a ketohexokinase inhibitor compound, a pharmaceutically acceptable salt, an ester or a stereoisomer thereof; a pharmaceutical composition and formulation containing the compound, the pharmaceutically acceptable salt, the ester or the stereoisomer thereof; a method for preparing the compound, the pharmaceutically acceptable salt, the ester or the stereoisomer thereof; and use of the compound, the pharmaceutically acceptable salt, the ester or the stereoisomer thereof in the manufacture of a medicament for treating and / or preventing KHK mediated diseases and related conditions.
Need to check novelty before this filing date? Find Prior Art